The Impact of Translation Delays on Clinical Trial Timelines

In clinical research, every second matters if we are to achieve medical breakthroughs and save lives. The journey from lab discovery to life-saving treatment is already long and complex—on average, it takes over a decade to bring a new drug to market. Clinical trials are a critical step in this process, operating under tight schedules and rigorous regulatory oversight. Any delay—no matter how small—can set off a chain reaction of setbacks.

A 2022 study by the Tufts Center for the Study of Drug Development found that trial delays cost sponsors between $600,000 and $8 million per day. That’s not just a financial burden—it’s time lost in the race to develop treatments for patients in need.

Delays in translation, for example, can prevent study materials from reaching local sites on time, slow down patient recruitment, and stall ethics and regulatory submissions. These aren’t just administrative hiccups—they’re barriers to progress that can ultimately affect patient outcomes.

In a field where timing is everything, streamlining every aspect of the trial process—including translation—is essential to delivering innovative therapies faster, safer, and more efficiently.

The Main Causes of Key Translation Delays in Clinical Trials

Clinical trial translation requires more than just linguistic fluency—it demands subject matter expertise, cultural awareness, and an understanding of regulatory standards across multiple regions.

1. Inefficient Project Management

Poor coordination between sponsors, CROs, and language service providers (LSPs) can create serious bottlenecks—especially when translations span multiple languages, countries, and regulatory environments. Misaligned timelines, unclear responsibilities, and a lack of centralized communication can all contribute to delays.

For instance, if an LSP receives documents in batches rather than in a coordinated package, it can result in duplicated efforts or inconsistent messaging. Similarly, if feedback loops between stakeholders are not clearly defined, revisions can get stuck in limbo, holding up the entire process. Without a dedicated project manager who understands the clinical and linguistic complexities involved, critical milestones may be missed, compromising study startup and site activation timelines.

2. Technology Gaps and Manual Processes

Another major source of delay is the continued reliance on outdated tools and manual workflows. When translations are managed through spreadsheets, email threads, and siloed file storage systems, the risk of errors, version mismatches, and time-consuming back-and-forth increases significantly. Without centralized translation management platforms, it becomes difficult to maintain oversight of what’s been translated, reviewed, approved, or updated—particularly across global teams.

3. Inconsistent Terminology and Lack of Glossaries

Clinical terminology must be consistent across all trial documents, especially when multiple languages are involved. Without a centralized glossary or terminology database, inconsistencies can creep in—leading to confusion, compliance issues, or even the need to retranslate entire documents.

4. Limited Access to Qualified Translators

Specialized medical translators with experience in clinical trial documentation are in high demand—and short supply. When sponsors or CROs rely on generalist providers, the risk of quality issues increases. These can trigger additional regulatory review cycles and further push back study timelines.

5. Regulatory Review and Rejections

Even minor translation errors can raise red flags with ethics committees and regulatory bodies. Rejected submissions not only damage credibility but can delay site activations by weeks or months. For this reason, ensuring translations meet the specific requirements of each region is critical to avoiding setbacks.

By identifying and addressing these causes early, clinical trial sponsors can avoid unnecessary delays and ensure that language is a bridge—not a barrier—to progress.

Staying on Schedule Starts with DTS Language Services

To prevent these issues, partnering with a language service provider specializing in clinical trial translations is important. Working with experts who are fluent not only in language but also in regulatory standards and medical terminology ensures that every document is accurate, compliant, and ready on time.

DTS Language Services is a trusted partner with over 50 years of experience supporting the life sciences industry. As an ISO-certified provider, DTS is recognized for delivering consistently high-quality translations backed by rigorous quality control, deep subject matter expertise, and responsive project management. With guaranteed turnaround times and a proven track record, DTS helps clients stay on schedule, reduce risk, and meet global regulatory requirements with confidence.

When every moment counts, choosing the right translation partner isn’t just a smart decision—it’s a critical step toward accelerating innovation and delivering life-changing treatments to the patients who need them most.